Literature DB >> 31751803

Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuria.

Rujipas Sirijatuphat1, Suchada Pongsuttiyakorn1, Orawan Supapueng2, Pattarachai Kiratisin3, Visanu Thamlikitkul4.   

Abstract

BACKGROUND: This study aimed to evaluate the practicality and advantage of Global Antimicrobial Resistance Surveillance System (GLASS) for surveillance of urine culture samples collected from patients with bacteriuria.
METHODS: GLASS has been implemented at a tertiary care university hospital in Thailand by using the web application program to collect clinical data and urine culture data from patients with positive urine culture.
RESULTS: There were 5085 urine samples from 3545 patients that were sent to our microbiology laboratory during June-December 2017. Bacteriuria was found in 1944 patients. Of those, 952 had urinary tract infection (UTI), and 1161 had colonization. Among UTI patients, hospital-acquired infection (HAI) was observed in 74.2 %, and community-acquired infection (CAI) was found in 28.7 %. E. coli and S. agalactiae were more frequently observed in CAI, but P. aeruginosa, P. mirabilis, E. faecium, and A. baumannii were more prevalent in HAI. UTI isolates demonstrated less resistance to antibiotics than colonized isolates. Non-duplicate isolates of bacteria demonstrated less resistance than duplicate isolates. E. coli, K. pneumoniae, P. aeruginosa, P. mirabilis, E. faecalis, and E. faecium causing HAI were more resistant to antibiotics than those causing CAI.
CONCLUSION: GLASS is feasible to implement and more beneficial than laboratory-based surveillance. This study collects additional information beyond GLASS including causative bacteria and colonizing bacteria; types of UTI; and more specific criteria to distinguish HAI from CAI so that such data can be used for developing more valid local guidelines for selecting antibiotic therapy in UTI patients in addition to AMR surveillance in urine samples.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bacteriuria; Global Antimicrobial Resistance Surveillance System (GLASS); Implementation; Surveillance; Urine culture samples

Mesh:

Year:  2019        PMID: 31751803     DOI: 10.1016/j.jgar.2019.11.009

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  6 in total

1.  Culture Requests and Multi-Drug Resistance among Suspected Urinary Tract Infections in Two Tertiary Hospitals in Freetown, Sierra Leone (2017-21): A Cross-Sectional Study.

Authors:  Julian S O Campbell; Saskia van Henten; Zikan Koroma; Ibrahim Franklyn Kamara; Gladys N Kamara; Hemant Deepak Shewade; Anthony D Harries
Journal:  Int J Environ Res Public Health       Date:  2022-04-16       Impact factor: 4.614

2.  Comprehensive assessment of holding urine as a behavioral risk factor for UTI in women and reasons for delayed voiding.

Authors:  S Jagtap; S Harikumar; V Vinayagamoorthy; S Mukhopadhyay; A Dongre
Journal:  BMC Infect Dis       Date:  2022-06-06       Impact factor: 3.667

3.  The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital.

Authors:  Watcharaphon Tangsawad; Chayanis Kositamongkol; Piriyaporn Chongtrakool; Pochamana Phisalprapa; Anupop Jitmuang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

4.  Urine Culture in Hospitalized Patients during 2014-2018: An Analysis on Pathogen Distribution and Drug Sensitivity.

Authors:  Dongkai Sun; Peishan Cong; Fengju Guan; Shuai Liu; Lijiang Sun; Guiming Zhang
Journal:  Dis Markers       Date:  2021-09-15       Impact factor: 3.434

5.  Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study.

Authors:  Rujipas Sirijatuphat; Sunee Chayangsu; Jintana Srisompong; Darat Ruangkriengsin; Visanu Thamlikitkul; Surapee Tiengrim; Walaiporn Wangchinda; Pornpan Koomanachai; Pinyo Rattanaumpawan
Journal:  Antibiotics (Basel)       Date:  2022-03-06

Review 6.  Considerations for diagnostic COVID-19 tests.

Authors:  Olivier Vandenberg; Delphine Martiny; Olivier Rochas; Alex van Belkum; Zisis Kozlakidis
Journal:  Nat Rev Microbiol       Date:  2020-10-14       Impact factor: 78.297

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.